Drugs / Iodized oil
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03511703 Background | May → Dec 2018 | hepatocellular carcinoma | Guangxi Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iodized oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03511703 ↗ |
| Route | Other | “Then another part of the chemotherapeutic drugs and lipiodol were mixed into emulsions for embolization.” NCT03511703 ↗ |